Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

629
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
629
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Oral Hypoglycemic Agents: Sulfonylureas01:17

Oral Hypoglycemic Agents: Sulfonylureas

196
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
196
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

486
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
486
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

207
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
207
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

182
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
182

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fixed Drug Eruption Inversus Associated With Meloxicam.

American journal of therapeutics·2026
Same author

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Associated with Multiple Drug Hypersensitivity Confirmed by Skin Testing.

Hospital pharmacy·2026
Same author

A novel method for rapid determination of risperidone in human plasma using Reversed-Phase Liquid Chromatography with Ultra-Violet detection.

La Tunisie medicale·2026
Same author

Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome Induced by Abiraterone: Evidence From a Positive Rechallenge.

American journal of therapeutics·2026
Same author

A Case of Acute Pancreatitis Related to Therapeutic Dosing With Colchicine and Review of the Literature.

American journal of therapeutics·2025
Same author

Bullous Fixed Drug Eruption to Metformin Following a DRESS Syndrome to Allopurinol: What's the Link?

Dermatitis : contact, atopic, occupational, drug·2025

Related Experiment Video

Updated: Jun 12, 2025

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.0K

Drug-Induced Hypouricemia.

Chaker Ben Salem1, Myriam Agrebi2, Dhouha Sahnoun2

  • 1Clinical Pharmacology, Pharmacovigilance Center of Sousse, Faculty of Medicine of Sousse, University of Sousse, Street Mohamed Karoui, 4002, Sousse, Tunisia. bensalem.c@gmail.com.

Drug Safety
|September 17, 2024
PubMed
Summary
This summary is machine-generated.

Hypouricemia, or low serum uric acid, can be caused by medications. This review summarizes drugs that lower uric acid levels, their mechanisms, and clinical importance.

More Related Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.0K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K

Related Experiment Videos

Last Updated: Jun 12, 2025

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

14.0K
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

12.0K
Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

2.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Nephrology

Background:

  • Hypouricemia is defined as serum uric acid levels ≤ 2.0 mg/dL.
  • It can result from various conditions, including liver disease, cancer, and impaired uric acid reabsorption.
  • Medications are a significant and often overlooked cause of hypouricemia.

Purpose of the Study:

  • To review and summarize medications that can induce hypouricemia.
  • To elucidate the mechanisms of action by which drugs lower uric acid levels.
  • To discuss the clinical significance of drug-induced hypouricemia.

Main Methods:

  • Literature review of studies on hypouricemia and medications.
  • Analysis of drug mechanisms affecting uric acid metabolism and excretion.
  • Synthesis of clinical data on drug-induced hypouricemia.

Main Results:

  • Drug-induced hypouricemia frequently results from overtreatment of hyperuricemia with urate-lowering therapies.
  • Xanthine oxidase inhibitors, uricosuric agents, and uricases are common culprits.
  • Drugs not primarily used for gout treatment can also decrease serum uric acid levels.

Conclusions:

  • Medications represent a crucial cause of hypouricemia, necessitating careful consideration in clinical practice.
  • Understanding drug mechanisms is key to managing hypouricemia.
  • Further research may clarify the clinical implications of various drug-induced hypouricemia cases.